Covered recipient · General Payments record
JESSALYN T TRUJILLO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,340.04
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $384.98 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $153.66 | 10 |
| Medtronic, Inc. | $139.64 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $29.54 | 2 |
| Amgen Inc. | $28.60 | 2 |
| Kiniksa Pharmaceuticals International, plc | $17.13 | 1 |
| SANOFI-AVENTIS U.S. LLC | $16.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $14.75 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116185215 | CMS |
| Amgen Inc. | $13.85 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116185218 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.86 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117966091 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.68 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117966089 | CMS |
| Kiniksa Pharmaceuticals International, plc | $17.13 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154854160 | CMS |
| Medtronic, Inc. | $80.65 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116933611 | CMS |
| Medtronic, Inc. | $58.99 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116933613 | CMS |
| PFIZER INC. | $15.09 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131073052 | CMS |
| PFIZER INC. | $29.20 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131339487 | CMS |
| PFIZER INC. | $17.51 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131750002 | CMS |
| PFIZER INC. | $20.53 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131887947 | CMS |
| PFIZER INC. | $0.74 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131985305 | CMS |
| PFIZER INC. | $27.60 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131759118 | CMS |
| PFIZER INC. | $0.58 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131924320 | CMS |
| PFIZER INC. | $20.91 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131988015 | CMS |
| PFIZER INC. | $0.90 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131057066 | CMS |
| PFIZER INC. | $20.60 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131180466 | CMS |
| SANOFI-AVENTIS U.S. LLC | $16.41 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139943053 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.